Epidemiology

Sally L. Glaser, Ellen T. Chang, Christina A. Clarke, Theresa H Keegan

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Hodgkin lymphoma (HL) is a relatively rare malignancy with a complex epidemiology. In addition to clinical and histological complexity, it shows substantial variation in incidence and risk factors across demographic factors and tumor characteristics. This chapter provides an overview of the epidemiology of HL with particular attention to this etiologic heterogeneity in incidence patterns, timing of exposure to common infections, the role of Epstein-Barr virus (EBV), altered immune function, genetic susceptibility, and selected lifestyle practices. Altogether, evidence to date points to HL as an uncommon outcome in genetically susceptible individuals of immune dysfunction provoked by early (i.e., childhood) and subsequent environmental exposures. However, given the variations in incidence rates and risk associations with age and tumor EBV status, among other factors, HL has been proposed to comprise four etiologically distinct entities-EBV-associated childhood HL, EBV-associated young-adult HL, EBV-associated HL in older adults (and in the immunosuppressed), and non-EBV-associated HL (occurring primarily in young adults). With this complexity, and the fact that associations with potential etiologic factors have not been strong and/or have low population prevalence, our understanding of risk factors for HL needs to advance considerably to meet the ultimate goal of disease prevention. Furthermore, to account for the considerable epidemiologic heterogeneity of HL, informative future work must be undertaken in diverse study populations of substantial size.

Original languageEnglish (US)
Title of host publicationHodgkin Lymphoma: A Comprehensive Overview, Second Edition
PublisherSpringer International Publishing
Pages3-26
Number of pages24
ISBN (Electronic)9783319125053
ISBN (Print)9783319125046
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Hodgkin Disease
Epidemiology
Human Herpesvirus 4
Young Adult
Incidence
Oncogenic Viruses
Epstein-Barr Virus Infections
Environmental Exposure
Genetic Predisposition to Disease
Population Density
Life Style
Neoplasms
Demography
Viruses

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Glaser, S. L., Chang, E. T., Clarke, C. A., & Keegan, T. H. (2015). Epidemiology. In Hodgkin Lymphoma: A Comprehensive Overview, Second Edition (pp. 3-26). Springer International Publishing. https://doi.org/10.1007/978-3-319-12505-3-1

Epidemiology. / Glaser, Sally L.; Chang, Ellen T.; Clarke, Christina A.; Keegan, Theresa H.

Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing, 2015. p. 3-26.

Research output: Chapter in Book/Report/Conference proceedingChapter

Glaser, SL, Chang, ET, Clarke, CA & Keegan, TH 2015, Epidemiology. in Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing, pp. 3-26. https://doi.org/10.1007/978-3-319-12505-3-1
Glaser SL, Chang ET, Clarke CA, Keegan TH. Epidemiology. In Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing. 2015. p. 3-26 https://doi.org/10.1007/978-3-319-12505-3-1
Glaser, Sally L. ; Chang, Ellen T. ; Clarke, Christina A. ; Keegan, Theresa H. / Epidemiology. Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing, 2015. pp. 3-26
@inbook{316fc9393a604f89ad99852eeaeacec4,
title = "Epidemiology",
abstract = "Hodgkin lymphoma (HL) is a relatively rare malignancy with a complex epidemiology. In addition to clinical and histological complexity, it shows substantial variation in incidence and risk factors across demographic factors and tumor characteristics. This chapter provides an overview of the epidemiology of HL with particular attention to this etiologic heterogeneity in incidence patterns, timing of exposure to common infections, the role of Epstein-Barr virus (EBV), altered immune function, genetic susceptibility, and selected lifestyle practices. Altogether, evidence to date points to HL as an uncommon outcome in genetically susceptible individuals of immune dysfunction provoked by early (i.e., childhood) and subsequent environmental exposures. However, given the variations in incidence rates and risk associations with age and tumor EBV status, among other factors, HL has been proposed to comprise four etiologically distinct entities-EBV-associated childhood HL, EBV-associated young-adult HL, EBV-associated HL in older adults (and in the immunosuppressed), and non-EBV-associated HL (occurring primarily in young adults). With this complexity, and the fact that associations with potential etiologic factors have not been strong and/or have low population prevalence, our understanding of risk factors for HL needs to advance considerably to meet the ultimate goal of disease prevention. Furthermore, to account for the considerable epidemiologic heterogeneity of HL, informative future work must be undertaken in diverse study populations of substantial size.",
author = "Glaser, {Sally L.} and Chang, {Ellen T.} and Clarke, {Christina A.} and Keegan, {Theresa H}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-12505-3-1",
language = "English (US)",
isbn = "9783319125046",
pages = "3--26",
booktitle = "Hodgkin Lymphoma: A Comprehensive Overview, Second Edition",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Epidemiology

AU - Glaser, Sally L.

AU - Chang, Ellen T.

AU - Clarke, Christina A.

AU - Keegan, Theresa H

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hodgkin lymphoma (HL) is a relatively rare malignancy with a complex epidemiology. In addition to clinical and histological complexity, it shows substantial variation in incidence and risk factors across demographic factors and tumor characteristics. This chapter provides an overview of the epidemiology of HL with particular attention to this etiologic heterogeneity in incidence patterns, timing of exposure to common infections, the role of Epstein-Barr virus (EBV), altered immune function, genetic susceptibility, and selected lifestyle practices. Altogether, evidence to date points to HL as an uncommon outcome in genetically susceptible individuals of immune dysfunction provoked by early (i.e., childhood) and subsequent environmental exposures. However, given the variations in incidence rates and risk associations with age and tumor EBV status, among other factors, HL has been proposed to comprise four etiologically distinct entities-EBV-associated childhood HL, EBV-associated young-adult HL, EBV-associated HL in older adults (and in the immunosuppressed), and non-EBV-associated HL (occurring primarily in young adults). With this complexity, and the fact that associations with potential etiologic factors have not been strong and/or have low population prevalence, our understanding of risk factors for HL needs to advance considerably to meet the ultimate goal of disease prevention. Furthermore, to account for the considerable epidemiologic heterogeneity of HL, informative future work must be undertaken in diverse study populations of substantial size.

AB - Hodgkin lymphoma (HL) is a relatively rare malignancy with a complex epidemiology. In addition to clinical and histological complexity, it shows substantial variation in incidence and risk factors across demographic factors and tumor characteristics. This chapter provides an overview of the epidemiology of HL with particular attention to this etiologic heterogeneity in incidence patterns, timing of exposure to common infections, the role of Epstein-Barr virus (EBV), altered immune function, genetic susceptibility, and selected lifestyle practices. Altogether, evidence to date points to HL as an uncommon outcome in genetically susceptible individuals of immune dysfunction provoked by early (i.e., childhood) and subsequent environmental exposures. However, given the variations in incidence rates and risk associations with age and tumor EBV status, among other factors, HL has been proposed to comprise four etiologically distinct entities-EBV-associated childhood HL, EBV-associated young-adult HL, EBV-associated HL in older adults (and in the immunosuppressed), and non-EBV-associated HL (occurring primarily in young adults). With this complexity, and the fact that associations with potential etiologic factors have not been strong and/or have low population prevalence, our understanding of risk factors for HL needs to advance considerably to meet the ultimate goal of disease prevention. Furthermore, to account for the considerable epidemiologic heterogeneity of HL, informative future work must be undertaken in diverse study populations of substantial size.

UR - http://www.scopus.com/inward/record.url?scp=84955702575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955702575&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12505-3-1

DO - 10.1007/978-3-319-12505-3-1

M3 - Chapter

AN - SCOPUS:84955702575

SN - 9783319125046

SP - 3

EP - 26

BT - Hodgkin Lymphoma: A Comprehensive Overview, Second Edition

PB - Springer International Publishing

ER -